Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis

Published:2018-01-16 Issue:4 Volume:47 Page:270-275
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Baecklund E¹,Backlin C¹,Rönnelid J²,Toes R³,Huizinga TWJ³,Åhlin E²,Askling J⁴⁵,Hochberg FH⁶,Klareskog L⁷,Kay J⁶,Smedby KE⁴⁵

Affiliation:

1. Department of Medical Sciences, Unit of Rheumatology, Uppsala University, Uppsala, Sweden

2. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

3. Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands

4. Department of Medicine, Unit of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden

5. Center of Hematology, Karolinska University Hospital, Stockholm, Sweden

6. Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA

7. Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

Funder

Lions Cancer Research Foundation

Swedish Cancer Society

King Gustav Vs 80-year Foundation

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2017.1376108

Reference16 articles.

1. Lymphoma development in patients with autoimmune and inflammatory disorders – What are the driving forces?

2. Rheumatoid Arthritis and Risk of Malignant Lymphoma: Is the Risk Still Increased?

3. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

4. Do rheumatoid arthritis and lymphoma share risk factors?: A comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis

5. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species;International Journal of Molecular Sciences;2022-08-04

2. Diffuse Large B-cell Lymphoma of the Tibia in a Patient With Longstanding Seropositive Rheumatoid Arthritis on Methotrexate;Cureus;2022-03-16